Somewhat Positive Press Coverage Somewhat Unlikely to Affect Select Medical (SEM) Stock Price

News headlines about Select Medical (NYSE:SEM) have trended somewhat positive on Sunday, Accern Sentiment reports. The research group identifies positive and negative press coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Select Medical earned a coverage optimism score of 0.18 on Accern’s scale. Accern also gave news coverage about the health services provider an impact score of 45.8581468812225 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

These are some of the media stories that may have effected Accern’s analysis:

Shares of Select Medical (NYSE SEM) opened at $16.60 on Friday. The company has a debt-to-equity ratio of 3.36, a current ratio of 1.51 and a quick ratio of 1.51. The firm has a market cap of $2,261.64, a PE ratio of 22.74, a price-to-earnings-growth ratio of 1.06 and a beta of 1.30. Select Medical has a 1 year low of $12.00 and a 1 year high of $19.77.

A number of brokerages recently issued reports on SEM. TheStreet cut shares of Select Medical from a “b-” rating to a “c+” rating in a research report on Friday, February 2nd. Zacks Investment Research cut shares of Select Medical from a “hold” rating to a “sell” rating in a research report on Saturday, February 3rd. ValuEngine upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd. Wells Fargo & Co began coverage on shares of Select Medical in a research report on Tuesday, January 30th. They issued an “outperform” rating and a $26.00 price objective for the company. Finally, Bank of America upgraded shares of Select Medical from an “underperform” rating to a “neutral” rating and set a $19.00 price objective for the company in a research report on Thursday, January 4th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and six have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $20.25.

In other Select Medical news, insider Martin F. Jackson sold 156,603 shares of the firm’s stock in a transaction dated Wednesday, December 13th. The shares were sold at an average price of $17.06, for a total value of $2,671,647.18. Following the completion of the sale, the insider now owns 1,790,601 shares in the company, valued at approximately $30,547,653.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Martin F. Jackson sold 134,029 shares of the firm’s stock in a transaction dated Friday, December 22nd. The shares were sold at an average price of $17.05, for a total transaction of $2,285,194.45. Following the completion of the sale, the insider now owns 1,717,944 shares of the company’s stock, valued at approximately $29,290,945.20. The disclosure for this sale can be found here. Insiders sold a total of 295,955 shares of company stock valued at $5,052,199 in the last 90 days. Corporate insiders own 19.93% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Somewhat Positive Press Coverage Somewhat Unlikely to Affect Select Medical (SEM) Stock Price” was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this report on another site, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this report can be viewed at https://www.dispatchtribunal.com/2018/02/18/somewhat-positive-press-coverage-somewhat-unlikely-to-affect-select-medical-sem-stock-price.html.

About Select Medical

Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company’s segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care.

Insider Buying and Selling by Quarter for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply